T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ameriprise Financial
AMP
$49.7B
| $768M | 0.16% |
6,146,215
+346,801
| +6% | +$44.2M |
|
152
Bunge Global
BG
$21.4B
| $750M | 0.15% |
8,545,425
+350,660
| +4% | +$31.2M |
|
153
Cooper Companies
COO
$15B
| $741M | 0.15% |
16,662,348
-1,290,880
| -7% | -$58.2M |
|
154
Workday
WDAY
$44.8B
| $737M | 0.15% |
9,652,139
-274,708
| -3% | -$23.4M |
|
155
American Express
AXP
$230B
| $735M | 0.15% |
9,459,586
-149,596
| -2% | -$11.9M |
|
156
Sensata Technologies
ST
$6.73B
| $723M | 0.15% |
13,710,634
-215,682
| -2% | -$12.1M |
|
|
N
157
DELISTED
Netsuite Inc
N
| $713M | 0.15% |
7,767,826
-99,441
| -1% | -$9.42M |
|
158
Akamai
AKAM
$16.8B
| $708M | 0.15% |
10,136,120
+5,369,092
| +113% | +$398M |
|
159
Liberty Global Class C
LBTYK
$3.4B
| $693M | 0.14% |
16,914,802
-5,888,330
| -26% | -$244M |
|
160
United Parcel Service
UPS
$88.8B
| $691M | 0.14% |
7,132,454
-193,282
| -3% | -$19.2M |
|
161
Abbott
ABT
$190B
| $689M | 0.14% |
14,029,888
+829,392
| +6% | +$39.8M |
|
162
VeriSign
VRSN
$26B
| $684M | 0.14% |
11,077,798
-22,071
| -0.2% | -$1.42M |
|
163
Martin Marietta Materials
MLM
$33.3B
| $679M | 0.14% |
4,801,102
-163,167
| -3% | -$23.8M |
|
|
WCN
164
Waste Connections
WCN
$42B
| $677M | 0.14% |
21,538,412
+11,582,331
| +116% | +$369M |
|
165
Bath & Body Works
BBWI
$3.81B
| $674M | 0.14% |
9,719,261
-482,517
| -5% | -$34.6M |
|
|
MBLY
166
DELISTED
Mobileye N.V.
MBLY
| $673M | 0.14% |
12,659,977
+1,252,678
| +11% | +$59.4M |
|
|
ETFC
167
DELISTED
E*Trade Financial Corporation
ETFC
| $671M | 0.14% |
22,390,410
-874,162
| -4% | -$25.7M |
|
|
XL
168
DELISTED
XL Group Ltd.
XL
| $670M | 0.14% |
18,003,126
+2,244,202
| +14% | +$84.1M |
|
169
Amgen
AMGN
$224B
| $669M | 0.14% |
4,355,987
-104,433
| -2% | -$16.7M |
|
170
Equifax
EFX
$21.4B
| $668M | 0.14% |
6,876,642
-14,701
| -0.2% | -$1.43M |
|
171
Zoetis
ZTS
$31.1B
| $660M | 0.14% |
13,687,426
-2,662,984
| -16% | -$127M |
|
172
Ecolab
ECL
$79.8B
| $660M | 0.14% |
5,834,225
-481,843
| -8% | -$55.4M |
|
173
Xylem
XYL
$28.8B
| $651M | 0.13% |
17,573,694
-413,520
| -2% | -$15M |
|
174
RPM International
RPM
$14.9B
| $642M | 0.13% |
13,116,106
+2,478,364
| +23% | +$122M |
|
175
Pentair
PNR
$10.7B
| $641M | 0.13% |
13,892,406
-7,357,569
| -35% | -$312M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.